The BRCA Foundation has as its mission to foster collaboration and accelerate research aimed at treating, curing and preventing BRCA cancers. The BRCA gene is a gene we all have, and one that helps repair ordinary DNA damage. People with a mutation in that gene, however, are at an extremely high risk of developing certain cancers, such as breast, prostate, and ovarian.
Since we were founded in 2015, we have awarded $2M, each, to Harvard, Stanford, and the University of California, San Francisco. This year, we are focusing on developing the next generation of BRCA experts and are investing $1M in young investigators across those institutions.
The foundation is guided by our Science & Technology Advisory Team (STAT), which is comprised of world-renowned scientists and visionary technology experts. This unique combination of advisors reflects the foundation’s innovative culture and our goal of leveraging big data to further research.
We’ve also launched two exciting initiatives with Color, a Bay Area health technology company: 1) the Family Testing Program, which subsidizes genetic testing and allows 1st-degree relatives (parents, siblings, and children) of known mutation carriers to test for the extremely reduced cost of $50; and 2) the BRCA Registry, which allows mutation carriers to register in order to be contacted about participating in research studies.
We thank you for supporting the BRCA Foundation. Our vision is a world in which individual lives— and families— are free of the threat of BRCA cancers, and we are confident we will one day be free of the BRCA specter.